COMPANY:

Abacus dx

"Abacus dx is thrilled to announce a new commercial partnership with Epredia for their full core anatomic pathology line of solutions. This collaboration enhances our innovative histology product portfolio, furthering our commitment to providing high-quality IVD solutions across the country...Effective July 1st, 2024, Abacus dx will distribute Epredia’s anatomic pathology solutions to the Clinical market in Australia and New Zealand."

"Just launched! Invivoscribe’s FLT3 ITD MRD Assay for Acute Myeloid Leukemia (AML)...The FLT3 ITD MRD Assay is a targeted, deep-sequencing assay to identify internal tandem duplications (ITD), the most common mutation of the FLT3 gene. Unlike flow cytometry assays which require fresh sample and are highly subjective, this assay is designed for use with previously isolated DNA for scalable sample batching and an automated Linux-based software, circumventing the need for costly in-house bioinformatics expertise."

"Abacus dx announced the release of the latest FISH probe from ZytoVision: ZytoLight® SPEC BCOR Dual Color Break Apart Probe*. The ZytoLight® SPEC BCOR Dual Color Break Apart Probe is designed to detect rearrangements involving the chromosomal region Xp11.4 harboring the BCOR gene."